Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Feb 11, 2017
Strategy

Building Bioverativ

How Biogen spinout Bioverativ plans to survive as stand-alone company
BioCentury | Jan 13, 2017
Clinical News

Afstyla regulatory update

BioCentury | Nov 17, 2016
Clinical News

Afstyla regulatory update

BioCentury | Nov 11, 2016
Company News

CHMP recommendations include HBV drug Vemlidy

BioCentury | Jun 6, 2016
Clinical News

Afstyla regulatory update

Items per page:
1 - 5 of 5
Help Center
Username
Request a Demo
Request Training
Ask a Question